Home » Botox Lawsuit » Birth Defects
Receive a free case review.
In response to reports linking Botox, Botox Cosmetic, and Myobloc to birth defects, the U.S. Food and Drug Administration (“FDA�) announced that it will be performing additional safety reviews to determine whether Botox injections in pregnant women lead to Botox birth defects. Consumer information recommends against Botox treatment when pregnant because of the risk of Botox birth defects.
In December 2008, Australian authorities reported that Dysport, an anti-aging wrinkle treatment, was administered to an expectant mother whose child was born deaf and blind. Dysport contains botulinum toxin Type A, the same active ingredient in Botox and Botox Cosmetic. The Cosmetic Physicians Society of Australasia (“CPSA�) has since issued warnings to doctors, advising them not to prescribe botulinum toxin to women who are pregnant, wish to become pregnant and those who are breastfeeding because of the high risk of Botox birth defects.
Although Dysport has been the subject of safety concerns in Australia,and Australian health regulators have warned of the potential of
|
Related Topics: Dangerous Product Alerts: |
In addition to Botox birth defects, botulinum toxin products have been linked to a variety of other adverse side effects, including droopy eyelids, numbness, headaches, respiratory failure, pneumonia, trouble talking, muscle weakness, paralysis and death. Public Citizen, a consumer advocacy group, has cited 180 cases of Botox infection, including 16 deaths.
If you received Botox injections during pregnancy, and your child has suffered Botox birth defects, contact a Botox lawyer at our firm today for a confidential and free case evaluation to see if you qualify for a Botox lawsuit.
Botox
Botox Cosmetic
Botulinum Toxin Type A
Myobloc
Botulinum Toxin Type B
1989
Black Box Warning
Wrinkles
Migraine Headaches
Hyperhidrosis
Birth defects
Pnuemonia
Respiratory Failure
Paralysis
Botulism
Death
Botax
Botux